Skip to main content
×
Home
    • Aa
    • Aa

Improving population health or the population itself? Health technology assessment and our genetic future

  • Ken Bassett (a1), Patricia M. Lee (a2), Carolyn J. Green (a1), Lisa Mitchell (a3) and Arminée Kazanjian (a1)...
Abstract

The province of British Columbia (BC), Canada is developing its first population-wide prenatal genetic screening program, known as triple-marker screening (TMS). TMS, initiated with a simple blood test, is most commonly used to screen for fetuses with the chromosomal abnormality known as Down syndrome or neural tube disorders. Women testing TMS-positive are offered diagnostic amniocentesis and, if the diagnosis is confirmed, selective second-trimester abortion. The project described in this study was initiated to address the broad range of issues arising from this testing technology and provides an example of the new type of health technology assessment (HTA) contribution emerging (and likely to become increasing necessary) in health policy development. With the advent of prenatal genetic screening programs, would-be parents gain the promise of identifying target conditions and, hence, the option of selective abortion of affected fetuses. There is considerable awareness that these developments pose challenges in every dimension (ethical, political, economic, and clinical) of the health-care environment. In the effort to construct an appropriate prenatal screening policy, therefore, administrators have understandably sought guidance from within the field of HTA. The report authors concluded that, within the restricted path open to it, the role of government is relatively clear. It has the responsibility to maintain equal access to prenatal testing, as to any other health service. It should also require maintenance of medical standards and evaluation of program performance. At the same time, policy-makers need actively to support those individuals born with disabilities and their families.

Copyright
References
Hide All
Asch A. 1999 Prenatal diagnosis and selective abortion: A challenge to practice and policy. Am J Public Health. 89: 16491657.
Baillie C, Hewison J. 1999 Antenatal screening: Obtaining selective consent to scanning, rather than screening, is possible. Letter. BMJ. 318: 805.
Bassett KL, Lee P, Green CJ, et al. 2000 Triple marker screening in British Columbia: Current practice, future options. Final Report made to Minister's Advisory Council on Women's Health. Vancouver, BC: University of BC, BC Office of Health Technology Assessment Report 00:14T.
Carroll JC, Reid AJ, Woodward CA, et al. 1997 Ontario Maternal Serum Screening program: Practices, knowledge and opinion of health care providers. CMAJ. 156: 775784.
Chodirker BN, Evans JA. 1993 Maternal serum AFP screening programs: The Manitoba experience. In: Current practice of prenatal diagnosis in Canada, vol. 13. Ottawa: Royal Commission on New Reproductive Technologies 536610.
Dick PT. 1996 Periodic health examination, 1996 update: 1: Prenatal screening for and diagnosis of Down syndrome: Canadian Task Force on the periodic health examination. CMAJ. 154: 465479.
EUCROMIC Workshop. 1997 Proceedings (1996: Paris) Prenatal diagnosis in Europe: Proceedings of an EUCROMIC Workshop, Paris, May 23-24, 1996. Eur J Hum Genet. 5 (Suppl 1): 190.
Gill M, Murday V, Slack J. 1987 An economic appraisal of screening for Down syndrome in pregnancy using maternal age and serum alpha feto-protein concentration. Soc Sci Med. 24: 725731.
Green CJ, Hadorn D, Bassett K, Kazanjian A. 1996 Routine ultrasound imaging in pregnancy: How evidence-based are the guidelines? Vancouver, BC: BC Office of Health Technology Assessment Aug;96: 2D.
Howe DT, Gornall R, Wellesley D, Boyle T, Barber J. 2000 Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans. BMJ. 320: 606610.
Lee PM, Sroka H. 1999 The missing voices in the BC experience of maternal serum screening. A Report.
Lippman A. 1999 Embodied knowledge and making sense of prenatal diagnosis. J Genet Counseling. 8: 255274.
Merz B. 1987 Matchmaking scheme solves Tay-Sacks problem. JAMA. 258: 26362639.
Mitchell L. 1994 The routinization of the other: Ultrasound, women and the fetus. In: Basen G, Eichler M, Lippman S, eds. Misconceptions: The social construction of choice and the new reproductive technologies, vol. 2. Hull, Quebec, Canada: Voyageur Press 146160.
Palomaki GE, Knight GJ, McCarthy JE, Haddow JE, Donhowe JM. 1997 Maternal serum screening for Down syndrome in the United States: A 1995 survey. Am J Obstet Gynecol. 176: 10461051.
Permaul-Woods JA, Carroll JC, Reid AJ, et al. 1999 Going the distance: The influence of practice location on the Ontario maternal serum screening program. CMAJ. 161: 381385.
Press N, Browner C. 1998 Characteristics of women who refuse an offer of prenatal diagnosis: Data from the California maternal serum alpha fetoprotein blood test experience. Am J Med Genet. 78: 433445.
Press N, Browner C. 1993 Collective fictions: Similarities in reasons for accepting maternal serum alpha-fetoprotein screening among women of diverse ethnic and social class backgrounds. Fetal Diagn Ther. 8 (Suppl 1): 97106.
Rapp R. 1993 Accounting for amniocentesis. In: Lindenbaum S, Lock M, eds. Knowledge, power, and practice: The anthropology of everyday life. Berkeley, CA: University of California Press 5578.
Rapp R. 1993 Sociocultural differences in the impact of amniocentesis: An anthropological research report. Fetal Diagn Ther. 8 (Suppl 1): 9096.
Royal Commission on New Reproductive Technologies. 1993 Prenatal Diagnosis for Congenital Anomalies and Genetic Disease. In: Proceed with care. Final report of the Royal Commission on New Reproductive Technologies, vol. 2. 777.
Royal Commission on New Reproductive Technologies. 1993 Prenatal Diagnosis for Congenital Anomalies and Genetic Disease. In: Proceed with care. Final report of the Royal Commission on New Reproductive Technologies, vol. 2. 804.
Sadovnick AD, Baird PA. 1983 A cost-benefit analysis of a population screening programme for neural tube defects. Prenat Diagn. 3: 117126.
Sadovnick AD, Baird PA. 1981 A cost-benefit analysis of prenatal detection of Down's syndrome and neural tube defects in older mothers. Am J Med Genet. 10: 367378.
Santalahti P. 1994 Literature review. Prenatal screening in Finland: Availability and women's decision-making and experiences. Research report. Stakes National Research and Development Centre for Welfare and Health 13.
Sheldon TA, Simpson J. 1991 Appraisal of a new scheme for prenatal screening for Down's syndrome. BMJ. 302: 11331136.
Smith DK, Shaw RW, Marteau TM. 1994 Informed consent to undergo serum screening for Down's syndrome: The gap between policy and practice. BMJ. 309: 776.
Stephenson P, Mitchell L. 1998 Social and cultural determinants of parental experiences with ultrasound detected foetal anomalies. British Columbia: British Columbia Medical Services Foundation Grant No. BCM98-0012.
Tabor A, Madsen M, Obel EB. 1986 Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1: 12871292.
Tudiver S. 1993 Manitoba voices: A qualitative study of women's experiences with technology in pregnancy. Prenatal diagnosis: Background and impact on individuals. Ottawa, Ontario: Royal Commission on New Reproductive Technologies 347460.
Wald NJ, Kennard A, Hackshaw A, McGuire A. 1998 Antenatal screening for Down's syndrome. Health Technol Assess. 2: 1112.
Wald NJ, Watt HC, Hackshaw AK. 1999 Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med. 341: 461467.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 2
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 69 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 24th October 2017. This data will be updated every 24 hours.